Synmosa has made developments in the cardiovascular, respiratory, urology, sex hormone, and oncology therapeutic fields to meet our objectives for healthcare and focus on the development of quality products for this purpose. In addition to developing our own brand name drugs and special generic medicines, we have introduced new patent drugs from our strategic allies and all our products are based on patient need. Synmosa has a comprehensive cardiovascular disease product line providing treatment for high blood pressure, high blood sugar, high blood cholesterol and heart failure. Our respiratory tract drugs have the largest domestic market share in Taiwan as does our complete set of hormone drugs which rank number one in domestic share. We have constructed a dedicated hormone factory, to the highest international standard, to produce products to meet the needs of women. Synmosa also focuses on developments in urology and oncology in response to aging population. We are using our marketing advantage, international authorization, and global strategic alliances to introduce new treatments and patent drug development as part of our effort to meet all patient needs Worldwide.
All Products( A to Z )
